Compound Detail
CHEMBL12089
BERBERINE CHLORIDE Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL12089 |
| Name | BERBERINE CHLORIDE |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | VKJGBAJNNALVAV-UHFFFAOYSA-M |
| Parent Compound | CHEMBL295124 |
| Active Moiety | CHEMBL295124 |
50
Targets
112
Activities
4
Assay Types
22
PK Parameters
20
Publications
6
Known Names
2
Indications
Molecular Properties
336.4
MW (Da)
3.10
ALogP
4
HBA
0
HBD
40.8
PSA (Ų)
0.67
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Colitis, Ulcerative Diabetes Mellitus
Activity Summary
IC50 90 meas. best 7.4
Ki 14 meas. best 7.23
EC50 5 meas. best 6.89
Kd 3 meas. best 7.64
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cell division protein FtsZ CHEMBL3999 | Kd | 7.64 | 7.64 | 23.0 | 1 |
| Acetylcholinesterase CHEMBL220 | IC50 | 7.4 | 6.12 | 40.0 | 4 |
| Unchecked CHEMBL612545 | Ki | 7.23 | 6.35 | 59.0 | 3 |
| Unchecked CHEMBL612545 | IC50 | 7.02 | 5.2067 | 95.0 | 9 |
| Human immunodeficiency virus 1 CHEMBL378 | EC50 | 6.89 | 6.89 | 130.0 | 1 |
| Plasmodium falciparum CHEMBL364 | EC50 | 6.66 | 6.51 | 218.0 | 2 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 6.56 | 6.56 | 274.0 | 1 |
| Acetylcholinesterase CHEMBL4078 | Ki | 6.54 | 6.54 | 289.0 | 1 |
| Acetylcholinesterase CHEMBL4078 | IC50 | 6.43 | 6.3057 | 374.0 | 7 |
| 5-hydroxytryptamine receptor 4 CHEMBL5017 | Ki | 6.43 | 6.43 | 370.0 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 6.38 | 6.38 | 412.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 6.36 | 6.36 | 433.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | Ki | 6.27 | 6.27 | 542.0 | 1 |
| Plasmodium yoelii CHEMBL612889 | IC50 | 6.26 | 6.26 | 548.0 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | IC50 | 6.22 | 6.22 | 601.0 | 1 |
| Human betaherpesvirus 5 CHEMBL371 | IC50 | 6.17 | 6.17 | 680.0 | 1 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | Ki | 6.13 | 6.13 | 742.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 6.01 | 6.01 | 968.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | IC50 | 5.89 | 5.89 | 1289.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 5.66 | 5.66 | 2187.0 | 1 |
| 5-hydroxytryptamine receptor 4 CHEMBL5017 | IC50 | 5.65 | 5.65 | 2222.0 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | IC50 | 5.55 | 5.55 | 2837.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.51 | 5.51 | 3100.0 | 1 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | IC50 | 5.51 | 5.51 | 3080.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | IC50 | 5.46 | 5.46 | 3437.0 | 1 |
| Serine/threonine-protein kinase Nek7 CHEMBL4849 | IC50 | 5.38 | 5.38 | 4200.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 5.35 | 5.35 | 4504.2 | 1 |
| HL-60 CHEMBL383 | IC50 | 5.23 | 4.895 | 5830.0 | 2 |
| KB CHEMBL398 | IC50 | 5.22 | 5.175 | 6030.0 | 2 |
| A549 CHEMBL392 | IC50 | 5.2 | 5.2 | 6270.0 | 1 |
| BGC-823 CHEMBL614526 | IC50 | 5.15 | 5.15 | 7040.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 5.08 | 4.78 | 8320.0 | 3 |
| HT-29 CHEMBL384 | IC50 | 5.07 | 5.07 | 8450.0 | 1 |
| Histone acetyltransferase p300 CHEMBL3784 | IC50 | 5.05 | 5.05 | 8910.0 | 1 |
| Cholinesterase CHEMBL5763 | Ki | 5.04 | 5.04 | 9200.0 | 1 |
| Cell division protein FtsZ CHEMBL3999 | IC50 | 5.0 | 4.9 | 10000.0 | 2 |
| SK-MEL-2 CHEMBL614917 | IC50 | 4.86 | 4.86 | 13760.0 | 1 |
| PC-3 CHEMBL390 | IC50 | 4.84 | 4.67 | 14390.0 | 2 |
| Serine/threonine-protein kinase Nek7 CHEMBL4849 | Kd | 4.81 | 4.81 | 15600.0 | 1 |
| D(1A) dopamine receptor CHEMBL2056 | IC50 | 4.81 | 4.81 | 15500.0 | 1 |
| Bel-7402 CHEMBL614279 | IC50 | 4.79 | 4.79 | 16280.0 | 1 |
| SK-OV-3 CHEMBL614925 | IC50 | 4.78 | 4.78 | 16440.0 | 1 |
| HCT-15 CHEMBL612263 | IC50 | 4.78 | 4.78 | 16590.0 | 1 |
| D(2) dopamine receptor CHEMBL217 | IC50 | 4.77 | 4.59 | 17100.0 | 2 |
| Cholinesterase CHEMBL5763 | IC50 | 4.74 | 4.74 | 18200.0 | 3 |
| Butyrylcholinesterase CHEMBL5077 | IC50 | 4.74 | 4.74 | 18200.0 | 3 |
| Cholinesterase CHEMBL1914 | IC50 | 4.72 | 4.525 | 18970.0 | 2 |
| MDA-MB-231 CHEMBL400 | IC50 | 4.69 | 4.69 | 20600.0 | 1 |
| Retinoic acid receptor RXR-alpha CHEMBL2061 | Kd | 4.61 | 4.61 | 24800.0 | 1 |
| SW-620 CHEMBL612262 | IC50 | 4.6 | 4.6 | 25000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 99.0 | ng.hr.mL-1 | Rattus norvegicus |
| Cmax | 0.07 | nM | Homo sapiens |
| Cmax | 0.14 | nM | Homo sapiens |
| Cmax | 0.13 | nM | Homo sapiens |
| Cmax | 1.4 | nM | Homo sapiens |
| Cmax | 4.0 | nM | Homo sapiens |
| Cmax | 6.7 | nM | Homo sapiens |
| Cmax | 1.7 | nM | Homo sapiens |
| Cmax | 5.6 | nM | Homo sapiens |
| Cmax | 8.601 | nM | Rattus norvegicus |
| F | 1.0 | % | Rattus norvegicus |
| F | 0.544 | % | Rattus norvegicus |
| Ka | 12400.0 | - | - |
| Ka | 29300.0 | - | - |
| Ka | 1.28 | 10'-5/M | Bos taurus |
| MRT | 31.51 | hr | Rattus norvegicus |
| T1/2 | 2.94 | hr | Homo sapiens |
| T1/2 | 28.98 | hr | Rattus norvegicus |
| Tmax | 1.0 | hr | Homo sapiens |
| Tmax | 1.0 | hr | Homo sapiens |
| Tmax | 2.0 | hr | Homo sapiens |
| Tmax | 2.0 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine